Table 1

Indications for Quetiapine Identified by Chart Review

Principal Listed Indication	Intent to Stop (n = 161)	%	Intent to Continue (n = 93)	%	p (Fisher's Exact Test)
Principal listed indication
BPAD	49	30.4	27	29.0	.88
Schizoaffective disorder	39	24.2	24	25.8	.88
Major depressive disorder	10	6.2	3	3.2	.38
Posttraumatic stress disorder	10	6.2	0	0.0	.02^*
Schizophrenia	9	5.6	8	8.6	.43
Impulse control disorder/IED	8	5.0	5	5.4	.55
Psychotic disorder NOS	6	3.7	7	7.5	.23
MDD with psychosis	6	3.7	3	3.2	1.00
Personality disorder	5	3.1	6	6.5	.33
Mood disorder NOS	4	2.5	5	5.4	.29
No active diagnosis	4	2.5	0	0.0	.30
Substance related	4	2.5	2	2.2	1.00
Anxiety, NOS	2	1.2	2	2.2	.63
Panic	1	0.6	0	0.0	1.00
Generalized anxiety disorder	1	0.6	0	0.0	1.00
Dysthymia	1	0.6	0	0.0	1.00
Obsessive compulsive disorder	1	0.6	0	0.0	1.00
Insomnia	1	0.6	0	0.0	1.00
Depressive disorder NOS	0	0.0	1	1.1	.37
Total	161	100.0	93	100.0
FDA indication (strict)	58	36.0	35	37.6	.89
Non-FDA indication (strict)	103	64.0	58	62.4	1.00
Mood or psychotic disorder	124	77.0	77	82.8	.19
No mood or psychotic disorder	37	23.0	16	17.2	.33